These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12795528)

  • 1. Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.
    Corbett TH; White K; Polin L; Kushner J; Paluch J; Shih C; Grossman CS
    Invest New Drugs; 2003 Feb; 21(1):33-45. PubMed ID: 12795528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin.
    Corbett TH; Panchapor C; Polin L; Lowichik N; Pugh S; White K; Kushner J; Meyer J; Czarnecki J; Chinnukroh S; Edelstein M; LoRusso P; Heilbrun L; Horwitz JP; Grieshaber C; Perni R; Wentland M; Coughlin S; Elenbaas S; Philion R; Rake J
    Invest New Drugs; 1999; 17(1):17-27. PubMed ID: 10555119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of batracylin (NSC-320846) against solid tumors of mice.
    Mucci-LoRusso P; Polin L; Bissery MC; Valeriote F; Plowman J; Luk GD; Corbett TH
    Invest New Drugs; 1989 Nov; 7(4):295-306. PubMed ID: 2557298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
    Bissery MC; Vrignaud P; Lavelle F; Chabot GG
    Anticancer Drugs; 1996 Jun; 7(4):437-60. PubMed ID: 8826613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.
    Mucci-LoRusso P; Polin L; Biernat LA; Valeriote FA; Corbett TH
    Invest New Drugs; 1990 Aug; 8(3):253-61. PubMed ID: 2177044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of DMP 840 against mouse and human solid tumor models.
    LoRusso P; Demchik L; Dan M; Polin L; Gross JL; Corbett TH
    Invest New Drugs; 1995; 13(3):195-203. PubMed ID: 8729946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.
    Dorr RT; Liddil JD; Sami SM; Remers W; Hersh EM; Alberts DS
    Anticancer Drugs; 2001 Mar; 12(3):213-20. PubMed ID: 11290869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II.
    Mistry P; Stewart AJ; Dangerfield W; Baker M; Liddle C; Bootle D; Kofler B; Laurie D; Denny WA; Baguley B; Charlton PA
    Anticancer Drugs; 2002 Jan; 13(1):15-28. PubMed ID: 11914637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical antitumor activity of bizelesin in mice.
    Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J
    Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical antitumor activity of XK469 (NSC 656889).
    LoRusso PM; Parchment R; Demchik L; Knight J; Polin L; Dzubow J; Behrens C; Harrison B; Trainor G; Corbett TH
    Invest New Drugs; 1998-1999; 16(4):287-96. PubMed ID: 10426660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity on murine tumors of a novel antitumor benzoylphenylurea derivative, HO-221.
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Fujimoto S; Tsukagoshi S; Taguchi T
    Cancer Chemother Pharmacol; 1991; 28(5):351-6. PubMed ID: 1914078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing mice.
    Polin L; White K; Kushner J; Paluch J; Simpson C; Pugh S; Edelstein MK; Hazeldine S; Fontana J; LoRusso P; Horwitz JP; Corbett TH
    Invest New Drugs; 2002 Feb; 20(1):13-22. PubMed ID: 12003190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.
    Bissery MC; Nguyen CH; Bisagni E; Vrignaud P; Lavelle F
    Invest New Drugs; 1993 Nov; 11(4):263-77. PubMed ID: 8157469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.
    Corbett TH; Bissery MC; Wozniak A; Plowman J; Polin L; Tapazoglou E; Dieckman J; Valeriote F
    Invest New Drugs; 1986; 4(3):207-20. PubMed ID: 3546183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
    Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.